- STAAR Surgical to Participate in Goldman Sachs 45th Annual Global Healthcare Conference
- STAAR Surgical Reports First Quarter 2024 Results
- STAAR Surgical Announces Milestone Strategic Agreement in U.S. with IQ Laser Vision
- STAAR Surgical Strengthens Leadership Team with Appointments of Nancy Sabin as Chief Marketing Officer and Nathaniel Sisitsky as General Counsel
- STAAR Surgical to Report First Quarter Results on May 7, 2024
- STAAR Surgical Announces Preliminary Net Sales for First Quarter 2024
- STAAR Surgical Celebrates Three Million Lens Milestone at ASCRS Meeting, Unveils New EVO ICL Data and Latest Innovation for 2024
- STAAR Surgical Celebrates Three Million Implantable Collamer® Lenses
More ▼
Key statistics
As of last trade, STAAR Surgical Co (SR3:STU) traded at 37.02, 49.09% above the 52 week low of 24.83 set on Feb 05, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 37.02 |
---|---|
High | 37.02 |
Low | 36.94 |
Bid | 35.16 |
Offer | 36.41 |
Previous close | 37.25 |
Average volume | 0.00 |
---|---|
Shares outstanding | 49.13m |
Free float | 48.85m |
P/E (TTM) | 130.83 |
Market cap | 1.99bn USD |
EPS (TTM) | 0.3093 USD |
Data delayed at least 15 minutes, as of Jun 07 2024.
More ▼